Nipro stock: US broker cuts target from JPY 2,500 to JPY 2,300 for Nipro stock

Published on 10/24/2026 at 04:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

The October 19 note kept Overweight and cut the target to JPY 2,300. November 9 results follow JPY 167.5 billion first-quarter revenue for Nipro stock.

Targets and operating milestones

On October 19, 2026, a US broker cut its Nipro target from JPY 2,500 to JPY 2,300 while retaining Overweight.
Nipro generated JPY 167.5 billion in revenue and JPY 7.7 billion operating profit in fiscal first quarter 2026.
Market capitalization stood at JPY 219.1 billion on October 23, 2026.

Nipro, JP3673600007, Illustration mit AI erstellt.

Nipro (ISIN JP3673600007) faced a target cut to JPY 2,300 on October 19, 2026, while the unnamed US broker kept its Overweight rating, according to Yahoo Finance. The note reduced the target from JPY 2,500 and left the stock facing a lower valuation reference before the next results date.

Quarterly numbers set the baseline

Nipro reported JPY 167.5 billion in revenue and JPY 7.7 billion in operating profit for the fiscal first quarter ended June 30, 2026. Its quarterly net income was JPY 3.8 billion, according to Investing.com. The figures give the target revision a concrete operating backdrop rather than making the analyst move a stand-alone valuation signal.

Three dated steps in the story

On June 30, 2026, Nipro completed its fiscal first quarter; on September 15, 2026, it reported conversion results for its 2026 euro-yen convertible bonds, according to Nipro. On October 1, 2026, its US subsidiary completed enrollment of 158 subjects in the GREAT pivotal trial for the investigational Golazo Peripheral Atherectomy System, as reported by MarketScreener.

What does the target cut mean?

The change from JPY 2,500 to JPY 2,300 is an 8.00 percent reduction, while the Overweight rating was retained. That combination points to a more cautious valuation framework, even as Nipro continues advancing a device program that could support its medical business after the trial follow-up period.

Results date sets the next checkpoint

Nipro's next earnings release is scheduled for November 9, 2026, according to MarketScreener. The report should show whether the first-quarter revenue base and operating profit trend continued into the six months ended September 30, 2026.

Japanese shares await the next report

Nipro was last at JPY 1,343.50 on the TSE on October 23, 2026 at 3:30 p.m. JST after the Japanese session. Its market capitalization was JPY 219.1 billion on the same date, placing the analyst target 71.27 percent above that last TSE price. The further course of trading is shown by the continuously updated real-time quote of Nipro stock.